Skip to content
PICO Portalanswers from OpenAlex

Interim Results from the IMPACT Study: Evidence for Prostate-specific Antigen Screening in BRCA2 Mutation Carriers

PaperCitations, authors & open-access status

Interim Results from the IMPACT Study: Evidence for Prostate-specific Antigen Screening in BRCA2 Mutation Carriers is a paper indexed in PICO Portal from OpenAlex.

How many citations does Interim Results from the IMPACT Study: Evidence for Prostate-specific Antigen Screening in BRCA2 Mutation Carriers have?

PICO Portalcitation count

Interim Results from the IMPACT Study: Evidence for Prostate-specific Antigen Screening in BRCA2 Mutation Carriers has 244 citations in the OpenAlex counts PICO Portal stores.

When was Interim Results from the IMPACT Study: Evidence for Prostate-specific Antigen Screening in BRCA2 Mutation Carriers published?

PICO Portalyear

Interim Results from the IMPACT Study: Evidence for Prostate-specific Antigen Screening in BRCA2 Mutation Carriers has 2019 year in the PICO Portal index.

What is the open-access status of Interim Results from the IMPACT Study: Evidence for Prostate-specific Antigen Screening in BRCA2 Mutation Carriers?

PICO Portaloa status

Interim Results from the IMPACT Study: Evidence for Prostate-specific Antigen Screening in BRCA2 Mutation Carriers has hybrid oa status in the PICO Portal index.

What is the DOI of Interim Results from the IMPACT Study: Evidence for Prostate-specific Antigen Screening in BRCA2 Mutation Carriers?

PICO Portaldoi

The DOI for Interim Results from the IMPACT Study: Evidence for Prostate-specific Antigen Screening in BRCA2 Mutation Carriers is on the source record.

What is the PMID of Interim Results from the IMPACT Study: Evidence for Prostate-specific Antigen Screening in BRCA2 Mutation Carriers?

PICO Portalpmid

The PMID for Interim Results from the IMPACT Study: Evidence for Prostate-specific Antigen Screening in BRCA2 Mutation Carriers is on the source record.

What is the OpenAlex record for Interim Results from the IMPACT Study: Evidence for Prostate-specific Antigen Screening in BRCA2 Mutation Carriers?

PICO Portalopenalex

The OpenAlex for Interim Results from the IMPACT Study: Evidence for Prostate-specific Antigen Screening in BRCA2 Mutation Carriers is on the source record.

Related on PICO Portal

470M+ articles · 14-day free trial